Th9, Th17, Treg Cells and their related cytokines in primary diagnosis of multiple myeloma
10.13303/j.cjbt.issn.1004-549x.2021.08.009
- VernacularTitle:Th9、Th17和Treg细胞及其细胞因子在初诊多发性骨髓瘤中的研究
- Author:
Yong GAO
1
;
Ping YU
1
;
Shukun HAN
1
;
Xiaohua LIANG
1
Author Information
1. Dalian Blood Center, Dalian 116001, China
- Publication Type:Journal Article
- Keywords:
multiple myeloma;
Th9;
Th17;
Treg cell;
IL-9;
IL-17;
TGF-β
- From:
Chinese Journal of Blood Transfusion
2021;34(8):840-843
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To detect the abnormal expression of Th9, Thl7, Treg cells, interleukin-9 (IL-9), interleukin-17 (IL-17) and transforming growth factor-β(TGF-β) in patients with multiple myeloma (MM), and to explore their roles in primary diagnosis of MM. 【Methods】 The level of Th9, Th17 and Treg cells in peripheral blood of 54 MM patients with(patient) and 45 healthy volunteers (control) were measured by flow cytometry, and the levels of IL-9, IL-17 and TGF-β were detected by ELISA. 【Results】 The percentages(%) of Th9, Thl7 in MM patients increased significantly in comparison to controls [1.37±0.39 vs 0.79±0.26; 2.02±0.41 vs 1.18±0.32] (P<0.05). The proportion(%) of CCD4+ CD25+ FoxP3+ Treg cells in patients was significantly lower than those in controls (4.92±0.83 vs 7.04±1.85, P<0.05). The expression levels (%) of IL-9 and IL-17 in the peripheral blood of patients were significantly higher than those in controls (25.74 1±7.33 vs 16.82±5.58; 11.01±3.71 vs 7.68 ± 2.57, P<0.05). The levels of TGF-β in patients and controls were (3.73±1.44)% vs (6.95±2.12)%, showing a significant decrease (P<0.05). 【Conclusion】 The abnormal percentage of Th9, Thl7, Treg cells and the abnormal expression levels of IL-9, IL-17, TGF-β in MM patients may play an important role in the initial diagnosis of MM.
